About Eversens
Eversens is a company based in Pamplona (Spain) founded in 2015 by Francisco J. Arregui and Juan Mari Perez Azpeitia. Eversens offers products and services including Breath Analysis Solutions. Eversens operates in a competitive market with competitors including Apieron, Linshom, Deep Breath Intelligence, Deversify and Medipines, among others.
- Headquarter Pamplona, Spain
- Founders Francisco J. Arregui, Juan Mari Perez Azpeitia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$59.25 K (USD), Grant
Nov 30, 2017
-
Investors
NIH
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eversens
Eversens offers a comprehensive portfolio of products and services, including Breath Analysis Solutions.
Tools for detecting health biomarkers through exhaled air analysis.
People of Eversens
Unlock access to complete
Unlock access to complete
Funding Insights of Eversens
Investors in Eversens
Eversens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, European Union and Sodena.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
A private capital fund is managed to support innovative projects.
|
Locked | Locked | Locked | |
|
Seed-stage micro VC investments are focused on European startups.
|
Locked | Locked | Locked |
Investor details for Eversens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eversens
Investment portfolio details for Eversens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eversens
Detailed financials for Eversens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eversens Comparisons
Peer comparison for Eversens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eversens
Eversens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apieron, Linshom, Deep Breath Intelligence, Deversify and Medipines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Functions as an asthma monitoring device for health management.
|
|
| Locked | Locked | Locked |
Developer of respiratory monitoring devices
|
|
| Locked | Locked | Locked |
AI and mass spectrometry platforms for personalized medicine are developed.
|
|
| Locked | Locked | Locked |
Breath analyzers for acetone concentration in exhaled air are developed.
|
|
| Locked | Locked | Locked |
Non-invasive respiratory measurement devices are developed for gas exchange assessment.
|
Detailed competitors of Eversens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eversens
Complete news archive for Eversens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eversens
Eversens was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Eversens is headquartered in Pamplona, Spain. It is registered at Pamplona, Navarra, Spain.
Eversens was founded in 2015 in Pamplona, Spain, within the health technology sector. Non-invasive clinical diagnosis systems are developed by the company to identify biomarkers in exhaled breath. The Evernoa device, a nitric oxide analyzer, is employed to measure the fraction of exhaled nitric oxide (FeNO), enabling the detection, monitoring, and prevention of asthma and related conditions without invasive procedures. Operations focus on diagnostic tools for respiratory health applications.
Eversens's top competitors include Lifeloc, Heroic-Faith and Linshom.
Eversens offers Breath Analysis Solutions.
Eversens has 5 investors. Key investors include NIH, European Union, Sodena, EIC Fund, and UN I+D+I Tech Transfer.